21-01-2021 дата публикации
Номер: US20210017120A1
Provided herein are compounds of formula I: 121-. (canceled)26. The method of claim 22 , wherein Z is hydrogen; X is hydrogen; and Y is hydrogen or halo.27. The method of claim 22 , wherein A is C-Caryl.28. The method of claim 27 , wherein A is phenyl.29. The method of claim 22 , wherein A is 5-15 membered heteroaryl.30. The method of claim 29 , wherein A is pyridyl.31. The method of claim 29 , wherein A is —N═CRRwhere Rand Rare defined as in .32. The method of claim 22 , wherein each R is hydrogen.331. The method of claim 22 , wherein one of the R groups is hydrogen and the other R group is C-Calkyl claim 22 , or wherein both the R groups are non-hydrogen substituents as defined in claim .34. The method of claim 33 , wherein R is methyl.35. The method of claim 22 , wherein each of R claim 22 , R claim 22 , and Ris independently claim 22 , hydrogen or methyl and Ris —CH—CH— or —CH—C(Me)-.37. The method of claim 22 , wherein the cancer expresses AKR1Creductase.38. The method of claim 22 , wherein the cancer is selected from adrenal gland claim 22 , bone claim 22 , brain claim 22 , breast claim 22 , bronchi claim 22 , colon and/or rectum claim 22 , gallbladder claim 22 , head and neck claim 22 , kidneys claim 22 , larynx claim 22 , liver claim 22 , lung claim 22 , neural tissue claim 22 , pancreas claim 22 , prostate claim 22 , parathyroid claim 22 , skin claim 22 , stomach claim 22 , and thyroid; and acute and chronic lymphocytic and granulocytic tumors claim 22 , adenocarcinoma claim 22 , adenoma claim 22 , basal cell carcinoma claim 22 , cervical dysplasia and in situ carcinoma claim 22 , Ewing's sarcoma claim 22 , epidermoid carcinomas claim 22 , giant cell tumor claim 22 , glioblastoma multiforma claim 22 , hairy-cell tumor claim 22 , intestinal ganglioneuroma claim 22 , hyperplastic corneal nerve tumor claim 22 , islet cell carcinoma claim 22 , Kaposi's sarcoma claim 22 , leiomyoma claim 22 , leukemias claim 22 , lymphomas claim 22 , malignant carcinoid claim 22 ...
Подробнее